Skip to main content
Premium Trial:

Request an Annual Quote

David Reiter

Luminex said that Senior VP, General Counsel, and Corporate Secretary David Reiter is resigning from the firm, effective on or around April 1, 2015. The firm said he resigned to pursue other interests and his departure is not the result of any disagreement with the company. Reiter will rejoin his independent legal practice, but he will serve as a consultant to Luminex from the time of his resignation until the end of 2015.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.